Depressive Disorder, Major trials recruiting in Maryland

All Depressive Disorder, Major trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Maryland: Baltimore
• A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
  NCT07573176 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Maryland: Baltimore
• A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
  NCT07227454 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Maryland: Baltimore
• Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
  NCT06511908 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Maryland: Bethesda